Cargando…
Vinorelbine plus 3-weekly trastuzumab in metastatic breast cancer: a single-centre phase 2 trial
BACKGROUND: After two studies reporting response rates higher than 70% in HER2-positive metastatic breast cancer with weekly trastuzumab and vinorelbine, we planned a phase 2 study to test activity of the same combination, with trastuzumab given every 3 weeks. METHODS: Patients with HER2-positive me...
Autores principales: | De Maio, Ermelinda, Pacilio, Carmen, Gravina, Adriano, Morabito, Alessandro, Di Rella, Francesca, Labonia, Vincenzo, Landi, Gabriella, Nuzzo, Francesco, Rossi, Emanuela, Silvestro, Pasqualina, Botti, Gerardo, Di Bonito, Maurizio, Curcio, Maria Pia, Formichelli, Franca, La Vecchia, Franca, Staiano, Maria, Maurea, Nicola, D'Aiuto, Giuseppe, D'Aiuto, Massimiliano, Thomas, Renato, Signoriello, Giuseppe, Perrone, Francesco, de Matteis, Andrea |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1832208/ https://www.ncbi.nlm.nih.gov/pubmed/17374151 http://dx.doi.org/10.1186/1471-2407-7-50 |
Ejemplares similares
-
Effects on quality of life of weekly docetaxel-based chemotherapy in patients with locally advanced or metastatic breast cancer: results of a single-centre randomized phase 3 trial
por: Nuzzo, Francesco, et al.
Publicado: (2011) -
Compliance and toxicity of adjuvant CMF in elderly breast cancer patients: a single-center experience
por: De Maio, Ermelinda, et al.
Publicado: (2005) -
Is epirubicin effective in first-line chemotherapy of metastatic breast cancer (MBC) after an epirubicin-containing adjuvant treatment? A single centre phase III trial
por: Pacilio, C, et al.
Publicado: (2006) -
Molecular profiles of screen detected vs. symptomatic breast cancer and their impact on survival: results from a clinical series
por: Crispo, Anna, et al.
Publicado: (2013) -
Combination of inositol and alpha lipoic acid in metabolic syndrome-affected women: a randomized placebo-controlled trial
por: Capasso, Immacolata, et al.
Publicado: (2013)